Abstract
This study is an application of the ROC technique to the determination of threshold values (TV) for the interpretation of serum thyroglobulin (Tg) measurements in the follow-up of differentiated thyroid cancer. Serum Tg was assayed using the Henning kit in 1466 samples from 245 individuals. A local or distant recurrence was assessed by clinical examination, radiological and scintigraphic investigations, and was present in 23 patients. The measurements were divided into four groups: 1) measurements performed less than 6 months after thyroidectomy; 2) measurements performed more than 6 months after thyroidectomy; 3) measurements performed during the suppression of pituitary secretion; 4) measurements performed during withdrawal of the substitutive therapy. An ROC curve was calculated for each group and for each curve three TVs were determined: TV1, TV2, and TV3 corresponding to a high sensitivity, a high specificity and a high sum of sensitivity and specificity respectively. TV1 is 3.12 μg/l in the four groups. TV2 is 44 μg/l, 19 μg/l and 30 μg/l, in the first, second, third and fourth groups respectively. TV3 is 35 μg/l in the first group, 3.12 μg/l in both the second and third groups and 30 μg/l in the fourth group. When the classical method allows the determination of only one threshold value, the ROC technique allows us to determine threshold values adapted to both the patient clinical status and the chosen sensitivity or specificity.
Similar content being viewed by others
References
Blahd WH, Drickman MV, Porter CW, Hill VA, Baum Gartner WA (1984) Serum thyroglobulin, a monitor of differentiated thyroid carcinoma in patients receiving thyroid hormone suppression therapy: concise communication. J Nucl Med 25:673–676
Bohner F, Seyss R (1984) TSH-Rezeptor-Autoantikörperbestimmung is der Schilddrüsenroutinediagnostik. Nucl Compact 15:188–191
Feldt-Rassmussen U, Holten I, Sand Hansen H (1983) Influence of thyroid substitution therapy and thyroid autoantibodies on the value of serum thyroglobulin in recurring thyroid cancer. Cancer 51:2240–2244
Green DM, Swets JA (1974) Signal detection theory and psychophysics. Huntington, New York
Liehn JC, Hannequin P, Amico S, Deschildre A, Elaerts J, Bajolet A, Valeyre J (1984) A new method for objective evaluation of cardiac parametric images. Eur J Nucl Med 9:446–452
Logerfo P, Colacchio D, Stillman T, Feind C (1977) Serum thyroglobulin and recurrent thyroid cancer. The Lancet 1:881–882
Metz CE (1978) Basic principes of ROC analysis. Semin Nucl Med 8:283–298
Oehr P, Biersack HJ, Hunermann B, Wincker C (1983) ROC analysis of single or combined CEA and TPA determination in a wilde spectrum of cancer patients. J Nucl Med 23:112 (abstr)
Schlossberg AH, Jacobson JC, Ibbertson HK (1979) Serum thyroglobulin in the diagnosis and management of thyroid carcinoma. Clin Endocrinol (Oxford) 10:17–27
Schlumberger M, Fragu P, Parmentier C (1983) Limites et indications du dosage de thyroglobuline chez les patients suivis pour épithélioma différencié de la thyroïde. Ann Endocrinol 44:279–281
Schneider AB, Pervos R (1978) Radioimmunoassay of human thyroglobulin: effect of antithyroglobulin antibodies. J Clin Endocrinol Metab 47:126–137
Sunderman FW (1975) Current concepts of “normal values”, and “discrimination values” in clinical chemistry. Clin Chem 21:1873–1877
van Herle AJ, Uller RP (1975) Elevated serum thyroglobulin: A marker of metastases in differentiated thyroid carcinomas. J Clin Invest 56:272–277
Van Herle AJ, Vassart G, Dumont JE (1979) Control of thyroglobulin synthesis and secretion. New Engl J Med 301:239–249 and 307–314
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hannequin, P., Liehn, J.C., Delisle, M.J. et al. ROC analysis in radioimmunoassay: An application to the interpretation of thyroglobulin measurement in the follow-up of thyroid carcinoma. Eur J Nucl Med 13, 203–206 (1987). https://doi.org/10.1007/BF00256492
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00256492